PDCD5 and prostate carcinoma: The decreased expression level of PDCD5 has been observed in various human tumors, and is correlated with high-grade astrocytic gliomas (9), a higher Gleason grade in prostate cancer (6) and an advanced International Federation of Gynecologists and Obstetricians stage and poorer survival in epithelial ovarian carcinomas (8).